Enrichment of cancer stem cell-like cells by culture in alginate gel beads

Journal of Biotechnology

Volumn 177, Issue 1, 2014, Pages 1-12

  Xu, Xiao xi ^a,b   Liu, Chang ^a,b   Liu, Yang ^a   Yang, Li ^c   Li, Nan ^a,b   Guo, Xin ^a   Sun, Guang wei ^a   Ma, Xiao jun ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Alginate gel bead; Cancer stem cell; Enrichment; Hypoxia inducible factor; Three dimensional culture

Indexed keywords

ALGINATE; BLAST ENRICHMENT; CELL CULTURE; DISEASES; PATHOLOGY;

ALGINATE GEL BEADS; ANTI-CANCER THERAPIES; CANCER STEM CELLS; EXPRESSION LEVELS; HYPOXIA-INDUCIBLE FACTORS; THREE-DIMENSIONAL CULTURE; THREEDIMENSIONAL (3-D); TWO DIMENSIONAL (2 D);

STEM CELLS;

ALGINATE GEL; ALGINIC ACID; BETA ACTIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; GELATINASE A; GELATINASE B; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MATRIX METALLOPROTEINASE 14; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; NOTCH1 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; SMOOTHENED PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; VASCULOTROPIN; ANTINEOPLASTIC AGENT; MICROSPHERE; TUMOR MARKER;

ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL EXPANSION; CELL HYPOXIA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CHEMISTRY; CULTURE TECHNIQUE; DRUG RESISTANCE; METABOLISM; MOUSE; NEOPLASMS; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; XENOGRAFT;

ALGINATES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICROSPHERES; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896080064     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2014.02.016     Document Type: Article

References (78)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
2. Atlasi Y., Mowla S., Ziaee S., Gokhale P., Andrews P. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 2008, 26:3068-3074.
3. Awad O., Yustein J.T., Shah P., Gul N., Katuri V., O'Neill A., Kong Y., Brown M.L., Toretsky J.A., Loeb D.M. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. PLoS ONE 2010, 5:e13943.
4. Brandl F., Sommer F., Goepferich A. Rational design of hydrogels for tissue engineering: impact of physical factors on cell behavior. Biomaterials 2007, 28:134-146.
5. Brown J.M., Giaccia A.J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 1998, 58:1408-1416.
6. Bugarski B., Li Q., Goosen M.F.A., Poncelet D., Neufeld R.J., Vunjak G. Electrostatic droplet generation: mechanism of polymer droplet formation. AIChE J. 1994, 40:1026-1031.
7. Campbell J.J., Davidenko N., Caffarel M.M., Cameron R.E., Watson C.J. A multifunctional 3D co-culture system for studies of mammary tissue morphogenesis and stem cell biology. PLoS ONE 2011, 6:e25661.
8. Cauffman G., Liebaers I., Van Steirteghem A., de Velde H.V. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 2006, 24:2685-2691.
9. Chen L., Xiao Z., Meng Y., Zhao Y., Han J., Su G., Chen B., Dai J. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials 2012, 33:1437-1444.
10. Chen S.F., Chang Y.C., Nieh S., Liu C.L., Yang C.Y., Lin Y.S. Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS ONE 2012, 7:e31864.
11. David B., Dufresne M., Nagel M.-D., Legallais C. In vitro assessment of encapsulated C3A hepatocytes functions in a fluidized bed bioreactor. Biotechnol. Prog. 2004, 20:1204-1212.
12. David L., Dulong V., Le Cerf D., Cazin L., Lamacz M., Vannier J.-P. Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of anticancer drug sensitivity. Acta Biomater. 2008, 4:256-263.
13. de Vos P., van Hoogmoed C.G., van Zanten J., Netter S., Strubbe J.H., Busscher H.J. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials 2003, 24:305-312.
14. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5:275-284.
15. Devolder R., Kong H.-J. Hydrogels for in vivo-like three-dimensional cellular studies. Wiley Interdiscip. Rev. Syst. Biol. Med. 2012, 4:351-365.
16. Dhoot N.O., Tobias C.A., Fischer I., Wheatley M.A. Peptide-modified alginate surfaces as a growth permissive substrate for neurite outgrowth. J. Biomed. Mater. Res. A 2004, 71:191-200.
17. Drury J.L., Mooney D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003, 24:4337-4351.
18. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
19. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2007, 15:504-514.
20. Feng S., Duan X., Lo P.-K., Liu S., Liu X., Chen H., Wang Q. Expansion of breast cancer stem cells with fibrous scaffolds. Integr. Biol. 2013, 5:768-777.
21. Fischbach C., Chen R., Matsumoto T., Schmelzle T., Brugge J.S., Polverini P.J., Mooney D.J. Engineering tumors with 3D scaffolds. Nat. Methods 2007, 4:855-860.
22. Fojo T. Cancer DNA repair mechanisms, and resistance to chemotherapy. J. Natl. Cancer Inst. 2001, 93:1434-1436.
23. Garcia M.P.S., Suarez-Penaranda J.M., Gayoso-Diz P., Barros-Angueira F., Gandara-Rey J.M., Garcia-Garcia A. Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target?. Cancer Lett. 2012, 323:11-19.
24. Ghajar C.M., Bissell M.J. Tumor engineering: the other face of tissue engineering. Tissue Eng. A 2010, 16:2153-2156.
25. Goh C.H., Heng P.W.S., Chan L.W. Alginates as a useful natural polymer for microencapsulation and therapeutic applications. Carbohydr. Polym. 2012, 88:1-12.
26. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., Lander E.S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
27. Hahn M.S., Teply B.A., Stevens M.M., Zeitels S.M., Langer R. Collagen composite hydrogels for vocal fold lamina propria restoration. Biomaterials 2006, 27:1104-1109.
28. Higgins D.F., Kimura K., Bernhardt W.M., Shrimanker N., Akai Y., Hohenstein B., Saito Y., Johnson R.S., Kretzler M., Cohen C.D., Eckardt K.-U., Iwano M., Haase V.H. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 2007, 117:3810-3820.
29. Hirschhaeuser F., Menne H., Dittfeld C., West J., Mueller-Klieser W., Kunz-Schughart L.A. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. 2010, 148:3-15.
30. Huber M.A., Kraut N., Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 2005, 17:548-558.
31. Klöck G., Pfeffermann A., Ryser C., Gröhn P., Kuttler B., Hahn H.-J., Zimmermann U. Biocompatibility of mannuronic acid-rich alginates. Biomaterials 1997, 18:707-713.
32. Kong H.J., Smith M.K., Mooney D.J. Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials 2003, 24:4023-4029.
33. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
34. Lee G.Y., Kenny P.A., Lee E.H., Bissell M.J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 2007, 4:359-365.
35. Lee J., Kim H.K., Rho J.Y., Han Y.M., Kim J. The human OCT-4 isoforms differ in their ability to confer self-renewal. J. Biol. Chem. 2006, 281:33554-33565.
36. Li F., Tiede B., Massague J., Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 2007, 17:3-14.
37. Li L., Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 2006, 66:4553-4557.
38. Li N., Xu X.X., Sun G.W., Guo X., Liu Y., Wang S.J., Zhang Y., Yu W.T., Wang W., Ma X.J. The effect of electrostatic microencapsulation process on biological properties of tumour cells. J. Microencapsul. 2013, 30:530-537.
39. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R.E., Hjelmeland A.B., Rich J.N. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
40. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980, 210:908-910.
41. Liu J., Tan Y., Zhang H., Zhang Y., Xu P., Chen J., Poh Y.-C., Tang K., Wang N., Huang B. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat. Mater. 2012, 11:734-741.
42. Ma S., Chan K.W., Hu L., Lee T.K.W., Wo J.Y.H., Ng I.L., Zheng B.J., Guan X.Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
43. Ma Y., Liang D., Liu J., Axcrona K., Kvalheim G., Stokke T., Nesland J.M., Suo Z. Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PLoS ONE 2011, 6:e29170.
44. Maguire T., Novik E., Schloss R., Yarmush M. Alginate-PLL microencapsulation: effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol. Bioeng. 2006, 93:581-591.
45. Malanchi I., Peinado H., Kassen D., Hussenet T., Metzger D., Chambon P., Huber M., Hohl D., Cano A., Birchmeier W., Huelsken J. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 2008, 452:650-653.
46. Mathieu J., Zhang Z., Zhou W., Wang A.J., Heddleston J.M., Pinna C.M.A., Hubaud A., Stadler B., Choi M., Bar M., Tewari M., Liu A., Vessella R., Rostomily R., Born D., Horwitz M., Ware C., Blau C.A., Cleary M.A., Rich J.N., Ruohola-Baker H. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 2011, 71:4640-4652.
47. Merchant A.A., Matsui W. Targeting Hedgehog - a cancer stem cell pathway. Clin. Cancer Res. 2010, 16:3130-3140.
48. Mimeault M., Batra S.K. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J. Cell. Mol. Med. 2013, 17:30-54.
49. Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Nat. Rev. Cancer 2006, 6:583-592.
50. Mitrus I., Bryndza E., Sochanik A., Szala S. Evolving models of tumor origin and progression. Tumor Biol. 2012, 33:911-917.
51. Murua A., Portero A., Orive G., Hernández R.M., de Castro M., Pedraz J.L. Cell microencapsulation technology: towards clinical application. J. Control. Release 2008, 132:76-83.
52. Nakaoka R., Hirano Y., Mooney D., Tsuchiya T., Matsuoka A. Study on the potential of RGD- and PHSRN-modified alginates as artificial extracellular matrices for engineering bone. J. Artif. Organs 2013, 16:284-293.
53. O'Brien C.A., Kreso A., Jamieson C.H. Cancer stem cells and self-renewal. Clin. Cancer Res. 2010, 16:3113-3120.
54. Ogasawara S., Yano H., Momosaki S., Nishida N., Takemoto Y., Kojiro S., Kojiro M. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues. Oncol. Rep. 2005, 13:1043-1048.
55. Okamoto A., Chikamatsu K., Sakakura K., Hatsushika K., Takahashi G., Masuyama K. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 2009, 45:633-639.
56. Pannuti A., Foreman K., Rizzo P., Osipo C., Golde T., Osborne B., Miele L. Targeting cancer stem cells through Notch signaling. Clin. Cancer Res. 2010, 16:3141-3152.
57. Peacock C.D., Watkins D.N. Cancer stem cells and the ontogeny of lung cancer. J. Clin. Oncol. 2008, 26:2883-2889.
58. Pedron S., Becka E., Harley B.A.C. Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid. Biomaterials 2013, 34:7408-7417.
59. Prestwich G.D. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Acc. Chem. Res. 2007, 41:139-148.
60. Rao S.S., DeJesus J., Short A.R., Otero J.J., Sarkar A., Winter J.O. Glioblastoma behaviors in three-dimensional collagen-hyaluronan composite hydrogels. ACS Appl. Mater. Interfaces 2013, 5:9276-9284.
61. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
62. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
63. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20:45-53.
64. Sapir Y., Kryukov O., Cohen S. Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials 2011, 32:1838-1847.
65. Shannon A.M., Bouchier-Hayes D.J., Condron C.M., Toomey D. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat. Rev. 2003, 29:297-307.
66. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
67. Siti-Ismail N., Bishop A.E., Polak J.M., Mantalaris A. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 2008, 29:3946-3952.
68. Smith B.H., Gazda L.S., Conn B.L., Jain K., Asina S., Levine D.M., Parker T.S., Laramore M.A., Martis P.C., Vinerean H.V., David E.M., Qiu S., Cordon-Cardo C., Hall R.D., Gordon B.R., Diehl C.H., Stenzel K.H., Rubin A.L. Three-dimensional culture of mouse renal carcinoma cells in agarose macrobeads selects for a subpopulation of cells with cancer stem cell or cancer progenitor properties. Cancer Res. 2011, 71:716-724.
69. Starke R.D., Ferraro F., Paschalaki K.E., Dryden N.H., McKinnon T.A.J., Sutton R.E., Payne E.M., Haskard D.O., Hughes A.D., Cutler D.F., Laffan M.A., Randi A.M. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011, 117:1071-1080.
70. Sun G., Fujii M., Sonoda A., Tokumaru Y., Matsunaga T., Habu N. Identification of stem-like cells in head and neck cancer cell lines. Anticancer Res. 2010, 30:2005-2010.
71. Takebe N., Harris P.J., Warren R.Q., Ivy S.P. Targeting cancer stem cells by inhibiting Wnt Notch, and Hedgehog pathways. Nat. Rev. Clin. Oncol. 2011, 8:97-106.
72. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
73. Xu X.-x., Liu C., Liu Y., Li N., Guo X., Wang S.-j., Sun G.-w., Wang W., Ma X.-j. Encapsulated human hepatocellular carcinoma cells by alginate gel beads as an in vitro metastasis model. Exp. Cell Res. 2013, 319:2135-2144.
74. Xu X., Gurski L.A., Zhang C., Harrington D.A., Farach-Carson M.C., Jia X.Q. Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials 2012, 33:9049-9060.
75. Yamashita T., Ji J., Budhu A., Forgues M., Yang W., Wang H.Y., Jia H., Ye Q., Qin L.X., Wauthier E., Reid L.M., Minato H., Honda M., Kaneko S., Tang Z.Y., Wang X.W. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136:1012-1024.
76. Yang X., Sarvestani S.K., Moeinzadeh S., He X., Jabbari E. Three-dimensional-engineered matrix to study cancer stem cells and tumorsphere formation: effect of matrix modulus. Tissue Eng. A 2013, 19:669-684.
77. Yin S.Y., Li J.J., Hu C., Chen X.H., Yao M., Yan M.X., Jiang G.P., Ge C., Xie H.Y., Wan D.F., Yang S.L., Zheng S.S., Gu J.R. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 2007, 120:1444-1450.
78. Zhu Z., Hao X., Yan M., Yao M., Ge C., Gu J., Li J. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int. J. Cancer 2010, 126:2067-2078.